Fampridine Accord is a medicine used to improve walking ability in adults with multiple sclerosis (MS) who have a walking disability. MS is a disease in which the immune system (the body’s defences) attacks and damages the covering around the nerves and the nerves themselves in the brain and spinal cord. Fampridine Accord is a ‘generic medicine’. This means that Fampridine Accord contains the same active substance and works in the same way as a ‘reference medicine’ already authorised in the EU called Fampyra. For more information on generic medicines, see the question-and-answer document below. Fampridine Accord contains the active substance fampridine.
Therapeutic Indication
### Therapeutic indication Fampridine Accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (EDSS 4-7).
Therapeutic Area (MeSH)
ATC Code
N07XX07
ATC Item
fampridine
Pharmacotherapeutic Group
Other nervous system drugs
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Fampridine | N/A | 氨吡啶 |
EMA Name
Fampridine Accord
Medicine Name
Fampridine Accord
Aliases
N/A